Accreditation: 12.75 AMA PRA Category 1 Credit™ | 12.75 ABIM MOC II | 12.75 Nursing Contact Hours | 12.75 ACPE Pharmacy
Venue: Hyatt Regency Bellevue, 900 Bellevue Way Northeast, Bellevue, WA, United States
Official conference page for Summit on Cancer Health Disparities (SCHD26). https://binaytara.org/projects/conferences/summit-on-cancer-health-disparities-schd26
Identification and mitigation of potential conflicts of interest
All conflict of interest has been identified and mitigated for individuals in control of contents.
Planning committee disclosure statement
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Conference Director
Binay Shah, MD, MHA No, I have not had a financial relationship with an ineligible company within the past 24 months.
Conference Chairs
David Aboulafia, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Ana Maria Lopez, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Catalysts
Shivaani Kummar, MD, FACP has a financial relationship (Researcher) with Incyte, SillaJen Inc., Deciphera Pharmaceuticals LLC, Moderna Inc, AstraZeneca LP, Immunitas Therapeutics, Inc., Transcenta Therapeutics, Inc., Bristol Myers Squibb, Adanate, Inc., 23andMe Inc., Gilead Sciences Inc., DOT Therapeutics-1 Inc., PMV Pharmaceuticals, Inc., Astex Pharmaceuticals Inc., Blueprint Medicines Corp., Parabilis Pharmaceuticals, Nuvectis Pharma, Inc.; financial relationship (Ownership Interest) with PATHOMIQ (co-founder), Fortress Biotech, Inc (equity), Sift Biosciences (Equity); financial relationship (Consultant) with Springworks Therapeutics, SeaGen, Bayer, Genome & Company, HarbourBiomed, BPGbio Therapeutics, Oxford Biotherapeutics, Mundibiopharma, BPGbio, Inc., Gilead, Mirati; GI Innovation Inc, XYone Therapeutics, Genome Insight, Aadi Biosciences, MOMA Therapeutics, Daiichi Sankyo, Parabilis, Boehringer Ingelheim Pharmcaeuticals.
Shailender Bhatia, MD has a financial relationship (Researcher) with Agenus; financial relationship (Consultant) with Bristol-Myers Squibb; financial relationship (Researcher) with Bristol-Myers Squibb; financial relationship (Researcher) with Checkmate/Regeneron; financial relationship (Researcher) with EMD-Serono; financial relationship (Consultant) with Ideaya; financial relationship (Consultant) with Immunocore; financial relationship (Researcher) with Incyte; financial relationship (Researcher) with Merck; financial relationship (Consultant) with Replimune; financial relationship (Researcher) with Trisalus.
Jerald Radich, MD has a financial relationship (Advisor) with BMS; financial relationship (Advisor) with Crossbow; financial relationship (Other) with Max Foundation; financial relationship (Advisor) with Novartis.
Christine Laine, MD has a financial relationship (Executive Role) with American College of Physicians; financial relationship (Employee) with American College of Physicians; financial relationship (Other) with Editor in Chief, Annals of Internal Medicine.
Planning Committee
Tianhong Li, MD, PhD has a financial relationship (Grant Or Contract) with Amgen; financial relationship (Grant Or Contract) with AstraZeneca; financial relationship (Grant Or Contract) with BMS; financial relationship (Grant Or Contract) with Chugai Pharma; financial relationship (Grant Or Contract) with Duality Biologics; financial relationship (Grant Or Contract) with Genentech/LaRoche; financial relationship (Grant Or Contract) with LabyRx Immuno-oncology; financial relationship (Grant Or Contract) with Marengo; financial relationship (Grant Or Contract) with Novartis; financial relationship (Grant Or Contract) with OncoC4/BioNTech; financial relationship (Grant Or Contract) with RasCal Therapeutics; financial relationship (Grant Or Contract) with Tempus; financial relationship (Grant Or Contract) with Xilio Therapeutics.
Marc R. Matrana, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Jorge E Cortes, MD has a financial relationship (Contractor) with Ascentage; financial relationship (Consultant) with Ascentage; financial relationship (Contractor) with BMS; financial relationship (Contractor) with Cyto Agents; financial relationship (Consultant) with Enliven; financial relationship (Consultant) with Incyte; financial relationship (Consultant) with Janssen; financial relationship (Contractor) with Kuro; financial relationship (Contractor) with Novartis; financial relationship (Consultant) with Novartis; financial relationship (Consultant) with Pfizer; financial relationship (Consultant) with Sun pharma; financial relationship (Contractor) with SunPharma; financial relationship (Consultant) with Syndax; financial relationship (Consultant) with Takeda; financial relationship (Consultant) with Tern Pharma; financial relationship (Contractor) with Tern Pharma.
Archie Rich, Other No, I have not had a financial relationship with an ineligible company within the past 24 months.
Siddhartha Yadav, MD has a financial relationship (Grant Or Contract) with 858 Therapeutics.; financial relationship (Grant Or Contract) with AstraZenca; financial relationship (Advisor) with AstraZeneca; financial relationship (Grant Or Contract) with Debiopharm; financial relationship (Grant Or Contract) with Exelixis; financial relationship (Grant Or Contract) with Incyte,; financial relationship (Grant Or Contract) with Repare Therapeutics.
Mark Daniel Pegram, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Manish Kohli, MD has a financial relationship (Advisor) with Integra PrecisionQ.
Eneida Rosario Nemecek, MD, MBA, MS has a financial relationship (Consultant) with Novartis, Medexus, Autolus, Mesoblast.
Srinivas Tantravahi, MBBS has a financial relationship (Consultant) with Karyopharm Therapeutics, Novartis, GSK, Sobi, BMS; financial relationship (Grant Or Contract) with Karyopharm Therapeutis.
Abstract Chairs
Martha Mims, MD, PhD has a financial relationship (Other) with Amgen; financial relationship (Grant Or Contract) with Aveo; financial relationship (Other) with Biogen IDEC; financial relationship (Grant Or Contract) with Celgene; financial relationship (Grant Or Contract) with DeNovo; financial relationship (Grant Or Contract) with Incyte.
Don Dizon, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Abstract Committee
Cecilia CS Yeung, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Swapna Thota, MD has a financial relationship (Other) with Pharmaessentia.
Tianhong Li, MD, PhD has a financial relationship (Grant Or Contract) with Amgen; financial relationship (Grant Or Contract) with AstraZeneca; financial relationship (Grant Or Contract) with BMS; financial relationship (Grant Or Contract) with Chugai Pharma; financial relationship (Grant Or Contract) with Duality Biologics; financial relationship (Grant Or Contract) with Genentech/LaRoche; financial relationship (Grant Or Contract) with LabyRx Immuno-oncology; financial relationship (Grant Or Contract) with Marengo; financial relationship (Grant Or Contract) with Novartis; financial relationship (Grant Or Contract) with OncoC4/BioNTech; financial relationship (Grant Or Contract) with RasCal Therapeutics; financial relationship (Grant Or Contract) with Tempus; financial relationship (Grant Or Contract) with Xilio Therapeutics.
Karen Ballen, MD has a financial relationship (Grant Or Contract) with StemLine Therapeutics.
Session Chairs
Linda Mach, PharmD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Christopher Li, MD, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Chermaine Wulff, BSN, OCN, RN No, I have not had a financial relationship with an ineligible company within the past 24 months.
Brian Persing, MD has a financial relationship (Consultant) with Astra Zeneca; financial relationship (Speaker) with Astra Zeneca; financial relationship (Speaker) with Diachii Sankyo; financial relationship (Speaker) with Johnson and Johnson; financial relationship (Consultant) with Regeneron; financial relationship (Speaker) with Regeneron.
Warren Phipps, MD, MPH has a financial relationship (Employee) with Fred Hutchinson Cancer Center; financial relationship (Researcher) with Fred Hutchinson Cancer Center.
Joseph Rosales, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Rebecca Johnson, MD has a financial relationship (Speaker) with Jazz Pharmaceuticals; financial relationship (Speaker) with Servier Pharmaceuticals.
Jin Mou, MD, MPH, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Catherine Duggan, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Joyce S Lee, PharmD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Carly Irwin, RN No, I have not had a financial relationship with an ineligible company within the past 24 months.
Banu Symington, MD has a financial relationship (Employee) with Memorial Hospital Sweetwater County.
Manish Kohli, MD has a financial relationship (Advisor) with Integra PrecisionQ.
Moderators
Fengting Yan, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Siddhartha Devarakonda, MD has a financial relationship (Grant Or Contract) with AstraZeneca; financial relationship (Professional Services) with Takeda; financial relationship (Professional Services) with Eli Lilly; financial relationship (Professional Services) with Johnson and Johnson; financial relationship (Professional Services) with Catalyst; financial relationship (Professional Services) with Acrotech; financial relationship (Professional Services) with Daiichi-Sankyo; financial relationship (Professional Services) with Nuvation; financial relationship (Other) with Apollomics; financial relationship (Professional Services) with BI; financial relationship (Advisor) with AZ; financial relationship (Speaker) with AZ; financial relationship (Advisor) with Amgen; financial relationship (Advisor) with Apollomics; financial relationship (Speaker) with BI; financial relationship (Advisor) with BMS; financial relationship (Advisor) with Ideaya; financial relationship (Speaker) with JNJ; financial relationship (Advisor) with Natera; financial relationship (Speaker) with Nuvation Bio.
Topic Presenters
Bipul Luitel, PhD has a financial relationship (Advisor) with Binaytara; financial relationship (Employee) with Growthzilla Inc.
Nandita Khera, MD, MPH has a financial relationship (Consultant) with Incyte; financial relationship (Employee) with Mayo Clinic.
Swathi Namburi, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Christopher Su, MD, MPH No, I have not had a financial relationship with an ineligible company within the past 24 months.
Hiba Khan, MD, MPH has a financial relationship (Researcher) with Amgen, MonteRosa Therapeutics; financial relationship (Advisor) with Johnson & Johnson, Natera, Fennec Pharmaceuticals.
Guannan Gong, PhD has a financial relationship (Ownership Interest) with CtrlTrial Inc..
Melinda Ann Biernacki, MD has a financial relationship (Employment) with Outpace Bio.
Dena Hedegaard, MPH No, I have not had a financial relationship with an ineligible company within the past 24 months.
Laura Marquez No, I have not had a financial relationship with an ineligible company within the past 24 months.
Kellie Lee No, I have not had a financial relationship with an ineligible company within the past 24 months.
Nihanthy Sreenath, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Archie Bleyer, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
David H. Noyd, MD, MPH has a financial relationship (Contractor) with Westat consultants to the NCI Surveillance Research Program and Clinical Consultants for Oncology Research and Evaluation Program through August 2025.
Nikita Nikita, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Wade Swenson, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Caroline Himbert, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Anusiyanthan Mariampillai, MD has a financial relationship (Employee) with Alaska Native Medical Center.
Robin Yabroff, MBA, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Panelists
Ira Klein, MD, MBA, FACP has a financial relationship (Advisor) with Gene Sprout; financial relationship (Employee) with Tempus AI.
Hina Khan, MD has a financial relationship (Other) with Boehringer Ingelheim: Advisory Board 03/2025; financial relationship (Other) with Daiichi-Sankyo: Advisory Board 10/2024; financial relationship (Other) with Lilly: Advisory Board 03/2025; financial relationship (Other) with Nuvalent" Advisory Board 02/2026; financial relationship (Other) with Regeneron: Advisory Board 12/2024.
Monica Yellowhair, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Barbara Goff, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Pamela Jean Simon, NP No, I have not had a financial relationship with an ineligible company within the past 24 months.
Benjamin O. Anderson, MD has a financial relationship (Consultant) with AstraZeneca.
Faculty
Mandi L. Pratt-Chapman, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Diane Mapes, Patient Advocate No, I have not had a financial relationship with an ineligible company within the past 24 months.
Irene Tamí‑Maury, DMD, DrPH, MSc has a financial relationship (Grant Or Contract) with NIH.
Anurekha Hall, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Shelley Fuld Nasso, MPP No, I have not had a financial relationship with an ineligible company within the past 24 months.
Kristin Nicholson, MSN, RN has a financial relationship (Employee) with Virginia Mason Franciscan Health.
Benjamin O. Anderson, MD, FACS has a financial relationship (Consultant) with AstraZeneca; financial relationship (Other) with Aurora; financial relationship (Other) with Aurora Technology.
Lisa Marie Force, MD, MPH has a financial relationship (Grant Or Contract) with Gates Foundation, St. Jude Children's Research Hospital, St. Baldrick's Foundation, ASCO Conquer Cancer Foundation, NIH Loan Repayment Program.
Tanya Wahl, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Mortuma Murry, DNP, CPNP-AC/PC No, I have not had a financial relationship with an ineligible company within the past 24 months.
Kalina Duncan, MPH, DrPH has a financial relationship (Speaker) with National Institutes of Health/National Cancer Institute.
Shashank Cingam, MD has a financial relationship (Advisor) with Janssen Pharamceuticals; financial relationship (Advisor) with Janssen Pharamceuticals; financial relationship (Grant Or Contract) with Pfizer.
Jaycee Wong, ARNP No, I have not had a financial relationship with an ineligible company within the past 24 months.
Diane Speelman, NP No, I have not had a financial relationship with an ineligible company within the past 24 months.
Ayokunle Olanrewaju, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Lesa Dawson, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Autumn Park No, I have not had a financial relationship with an ineligible company within the past 24 months.
Anao Zhang, PhD has a financial relationship (Ownership Interest) with EntertainMeWell Inc. (Founder); financial relationship (Employee) with University of Washington.
Tara Shah, BSN has a financial relationship (Employee) with Binaytara.
Tiffany Go, MPA, CPCHE No, I have not had a financial relationship with an ineligible company within the past 24 months.
Karan Sood, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Nicole Saint Clair, MD has a financial relationship (Executive Role) with Regence BlueShield.
Gumbo D. Silas, MPH No, I have not had a financial relationship with an ineligible company within the past 24 months.
Faina Spaeth, ARNP No, I have not had a financial relationship with an ineligible company within the past 24 months.
Kenn Chi Ndi, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Rafaella Litvin, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Nissim Benizri, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Savannah Allen, MPH No, I have not had a financial relationship with an ineligible company within the past 24 months.
Prajakta Adsul, MPH, PhD, MBBS No, I have not had a financial relationship with an ineligible company within the past 24 months.
Grzegorz Nowakowski, MD has a financial relationship (Employee) with Daiichi Sankyo.
Daniela Buscariollo, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Tracy Ekberg, RN No, I have not had a financial relationship with an ineligible company within the past 24 months.
Jasmine Kamboj, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.
Hank G Kaplan, MD has a financial relationship (Advisor) with Criterium Inc; financial relationship (Grant Or Contract) with Illumina; financial relationship (Grant Or Contract) with Kuni Foundation; financial relationship (Executive Role) with Leader, now Leader Emeritus The Initiative for Molecular and Genomic Evaluation of Cancer Paul G. Allen Research Center Swedish Cancer Institute; financial relationship (Grant Or Contract) with Pfizer; financial relationship (Executive Role) with Sr. Medical & Research Director for Breast Cancer & Translational Genomics Research Swedish Cancer Institute; financial relationship (Researcher) with Swedish Cancer Institute; financial relationship (Employee) with Swedish Cancer Institute; financial relationship (Grant Or Contract) with Swedish Foundation; financial relationship (Ownership Interest) with own public traded common stock in Boston Scientific, Lilly, Merck, Stryker and United Health.
Staff
Hemanta Neupane, MPH No, I have not had a financial relationship with an ineligible company within the past 24 months.
Audrey Kerby No, I have not had a financial relationship with an ineligible company within the past 24 months.
Prity Lata Chakraborty, MPH No, I have not had a financial relationship with an ineligible company within the past 24 months.
Bhawana Srivastava, MBA No, I have not had a financial relationship with an ineligible company within the past 24 months.
